Want to see our favorite hGH
supplement? Click here!
|
Obesity and Inhibition of HGH (Growth Hormone)
secretion
Ozata M, Dieguez C, Casanueva FF.
Endocrine Section, Complejo Hospitalario Universitario de Santiago and
Department of Medicine, University of Santiago de Compostela, E-15780
Santiago de Compostela, Spain.
GH secretion is regulated by hypothalamic and peripheral hormones under
a very complex interplay. Superimposed on this regulation, signals of a
metabolic nature connect GH secretion with the metabolic and energetic
homeostasis of a given individual. GH secretion is enhanced in
malnutrition and is severely impeded in obesity, but no information is
available to explain why GH secretion is severely impeded or blocked in
excess adiposity. Obesity is associated with high plasma levels of
leptin, and leptin participates at the hypothalamic and pituitary levels
in the regulation of GH secretion. Thus, it has been postulated that the
inhibitory action of obesity on GH discharge may be mediated by excess
leptin levels. The only situation in which obesity does not parallel
leptin values is the rare case of morbid obesity due to leptin
deficiency caused by missense mutation of the leptin gene. To understand
the causes of GH blockade presented in obesity, patients with both
homozygous and heterozygous mutations of the leptin gene and matched
controls for both sex and body mass index (BMI) were studied. Three
homozygous and 5 heterozygous patients with leptin gene mutations as
well as 13 control subjects were studied. In all subjects basal levels
of leptin and GH values stimulated by the combined administration of
GHRH plus GH-releasing peptide-6 (GHRP-6) were analyzed. To analyze the
effects of obesity and leptin levels, 5 groups were designed, all them
matched by sex and adiposity. The number of subjects (n), leptin levels
in micrograms per liter, and adiposity in BMI were as follows: nonobese
subjects: n = 5, BMI = 22.1 +/- 0.9 kg/m2, leptin = 5.4 +/- 0.9;
heterozygous patients: n = 5, BMI = 27.0 +/- 1.0 kg/m2, leptin = 2.3 +/-
0.1; controls for the heterozygous group: n = 5, BMI = 24.7 +/- 1.1
kg/m2, leptin = 5.7 +/- 1.2; homozygous patients: n = 3, BMI = 54.4 +/-
0.2 kg/m2, leptin = 1.0 +/- 0.2; and controls for the homozygous group:
n = 3, BMI = 50.3 +/- 2.0 kg/m2, leptin = 35.0 +/- 6.6. In these matched
groups, the GHRH- and GHRP-6-stimulated GH secretion (mean peak +/- SE;
micrograms per liter) was: nonobese, 86.8 +/- 8.9 [significantly higher
than heterozygous (28.6 +/- 4.9) and control for heterozygous (39.9 +/-
10.4)]; homozygous group, 9.4 +/- 3.0; control for homozygous, 9.3 +/-
1.0 (significantly lower than the heterozygous, control for
heterozygous, and nonobese groups). Hence, it appeared that GH discharge
was negatively conditioned by adiposity and was not influenced by leptin
levels. To further analyze this observation, a correlation analysis
showed that GH peaks were negatively correlated with BMI in the 13
control subjects as well as in the 8 leptin-deficient patients. On the
contrary, the GH peaks were negatively correlated with leptin levels in
controls, but showed the opposite pattern in homo- and heterozygous
patients. In conclusion, the GH secretion blockade, which is
characteristic of obese states, is due to adiposity or some factor
linked to adiposity, but not to elevated plasma leptin levels.
More
HGH Related Obesity Articles
Click here to Buy HGH Human Growth
Hormone
HGH Index
Human Growth Hormone Antiaging
HGH ~ Anti Aging News
Human Growth Hormone (HGH) Antiaging Articles
More Aging & Health Resources (HGH)
Health Treatment, Resources, Articles
Human Growth Hormone (HGH) Antiaging Articles
Human Growth Hormone *HGH* Resources
Anti-Aging HGH Related Resource Articles
HGH Academy ~ Resources
HGH Academy ~ More Articles
HGH Growth Hormone Resources
Human Growth Hormones - HGH Resources
Aging Process
Human Growth Hormone Antiaging HGH Articles
HGH - Side Effects, Articles
Human Growth Hormone, HGH Enhancers
Human Growth Hormone Therapy -- HGH
HGH Related Articles on Antiaging
HGH Human Growth Hormone
The information on this website is not intended to cure,
prevent, or treat any disease. The information can be used for informational
purposes only. If you suspect you may have a medical problem, contact your
licensed health care practitioner. Please see our terms of use, disclaimer, and
privacy policy for more details.
Contact us: webmaster [at] hghacademy.com
|